Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals, Molecular Devices

Serologicals Acquires Upstate and Will Issue Shares to Molecular Devices

Serologicals will acquire Upstate Group for $205 million in stock and cash, according to SEC documents filed this week.

As part of the acquisition, Serologicals will issue shares to Molecular Devices and other Upstate shareholders, the company said in its 8-K filing.

Molecular Devices in 2001 acquired approximately a 20 percent stake in Argonex, the parent company of Upstate Biotechnology, for $10 million in cash. As part of the deal, the companies announced a 10-year strategic partnership to provide new consumable reagent kits to the high-throughput screening market.

The transaction is subject to adjustment for amounts required to repay Upstate’s debts and expenses and Upstate’s working capital on the closing of the deal.

Atlanta-based Serologicals said that it will issue up to 5 million shares its common stock, which closed at $23.23 Tuesday, and the balance of the price will be paid in cash.

Upstate sells cell signaling research reagents to academic, biotech, and pharmaceutical investigators. Serologicals expects the deal will provide the company with a significant presence in the preclinical drug screening and target validation market, with a focus on kinase screening and protein interaction. The firm also said that it expects the Upstate and Chemicon subsidiaries would launch approximately 1,500 new research products per year.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.